Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)

Gyre Therapeutics (GYRE) has disclosed Interest Coverage Ratio for 9 consecutive years, with 25.62 as the latest value for Q1 2024.

  • Quarterly Interest Coverage Ratio rose 147.23% to 25.62 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 51.31 through Dec 2024, up 149.07% year-over-year, with the annual reading at 25.92 for FY2023, 486.95% down from the prior year.
  • Interest Coverage Ratio for Q1 2024 was 25.62 at Gyre Therapeutics, up from 10.36 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 25.62 in Q1 2024, with the low at 2300.0 in Q3 2020.
  • Average Interest Coverage Ratio over 3 years is 660.21, with a median of 183.23 recorded in 2020.
  • Peak annual rise in Interest Coverage Ratio hit 147.23% in 2024, while the deepest fall reached 147.23% in 2024.
  • Over 3 years, Interest Coverage Ratio stood at 376.82 in 2020, then surged by 102.75% to 10.36 in 2023, then skyrocketed by 147.23% to 25.62 in 2024.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 25.62, 10.36, and 376.82 for Q1 2024, Q1 2023, and Q4 2020 respectively.